Shannon Amoils

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 372 citations · Full text

Medicine, Cardiology, Internal Medicine +11

High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction

Andrew R. Chapman, Philip D Adamson, Anoop Shah et al. · Circulation · 2019 · 202 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

Philip M. Bath, Polly Scutt, Jason P. Appleton et al. · The Lancet · 2019 · 194 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial

Atul Anand, Kuan Ken Lee, Andrew R. Chapman et al. · Circulation · 2021 · 165 citations · Full text

Medicine, Cardiology, Internal Medicine +16